Standards of Care for Cancer Survivors

We’re grateful for guest blogger Nina Miller from the American College of Surgeons’ Commission on Cancer. In this blog she’s provided insights for Fight CRC readers into how the medical community is recognizing the need to establish standards of care for cancer survivors. With a growing population of survivors, the need for healthcare providers to help survivors…  Read More

May 2015 Webinar– Liver Metastases

About the Webinar A common site for advanced colorectal cancer to spread is the liver. In this webinar we will discuss why that happens and some treatment options available for patients facing liver metastases. Presented By: MARWAN G. FAKIH, M.D. Dr. Fakih received his Medical Doctorate from the American University of Beirut in 1992. He subsequently…  Read More

Let’s Get Ready to ASCO

This week Fight Colorectal Cancer is preparing for the American Society of Clinical Oncology (ASCO) Annual Conference in Chicago. LET’S GET READY TO ASCO…..!!!!!!!!!! The Fight CRC team is headed to ASCO to learn about groundbreaking medical and scientific research. Our goal is to ensure YOU (the patients, caregivers, friends, medical workers or others touched by this disease) have real-time…  Read More

Anesthesia, Colonoscopy and Co-Pays

There’s a new update on colonoscopy coverage! Guidance from Health and Human Services (HHS) indicates that issuers cannot impose cost-sharing for anesthesia services performed in connection with preventive colonoscopies. We’ll break it down a little bit… The Background Since the implementation of the Affordable Care Act (ACA), there has been confusion about preventive colorectal cancer screening and costs.…  Read More


Since the inception of Fight Colorectal Cancer (Fight CRC), we have advocated for and supported cancer research. Today kicks off the first off many blogs where I will update you on the latest clinical trials for colorectal cancer research. Learn the process of clinical trials. NCI’s Colon Task Force First – some background. Nancy Roach, our founder…  Read More

Ramucirumab – A New Treatment Option

The FDA approved the use of the drug ramucirumab (brand name Cyramza®) on April 24, 2015 for patients with metastatic colorectal cancer in combination with FOLFIRI. Ramucirumab with FOLFIRI is now approved for patients whose cancer has progressed during or after treatment with first line therapies (typically FOLFOX and bevacizumab (Avastin®). Ramucirumab was approved after the…  Read More